23-Mar-2020 | Zion Market Research
Zion Market Research has published a new report titled “Antiviral Drugs Treatment Market by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others); by Type (Branded, and Generic); By Application (HIV, Hepatitis, Herpes, Influenza, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2026”. According to the report, global demand for Antiviral Drugs Treatment market was valued at approximately USD 56.2 billion in 2019, and is expected to generate revenue of around USD 65.90 billion by end of 2026, growing at a CAGR of around 2.3% between 2019 and 2026.
Browse the full “Antiviral Drugs Treatment Market by Drug Class (DNA polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), by Type (Branded, and Generic), and Application (HIV, Hepatitis, Herpes, Influenza, and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026.” Report at https://www.zionmarketresearch.com/report/antiviral-drugs-treatment-market
Viral infections have caused millions of human casualties worldwide across human history, prompting the production of antiviral drugs in urgent need. A new period of antiviral drug production began in June 1963, when the first antiviral medication, idoxuridine, was approved. Antiviral drugs pertain to the class of medicines that have been used to treat viral infections including HIV, measles, hepatitis, and influenza. In general such medications are distributed in the form of vaccines. Moreover, most of these medications are used for common viral infections, while some (full-spectrum antiviral drugs) are effective against a large range of viruses.
Based on Drug Class, global Antiviral Drugs Treatment market is segmented into DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others.
Based on Type market is segmented into Branded, and Generic.
The Application segment of the Antiviral Drugs Treatment market is categorized into HIV and Hepatitis, Herpes, Influenza, and others.
North America held largest revenue share of the global Antiviral Drugs Treatment market in 2019. This is attributed to the existence of key players in the region, accessibility of sophisticated healthcare infrastructure, and cumulative consciousness of viral diseases. Cumulative patient population, refining economic steadiness, and the presence of a robust generic drugs market in South Asian countries are certain key factors expected to provide the Asia Pacific market with growing opportunities.
Major players in Antiviral Drugs Treatment market are Gilead Sciences; F. Hoffmann-La Roche AG; GlaxoSmithKline plc; AbbVie; Merck & Co., Inc.; Johnson & Johnson Services, Inc.; Bristol-Myers Squibb Company; Cipla Inc.; Aurobindo Pharma; and Dr. Reddy’s Laboratories Ltd. & Co., Inc.
The report segment of global Antiviral Drugs Treatment market as follows:
Global Antiviral Drugs Treatment Market: Drug Class
Global Antiviral Drugs Treatment Market: By Type
Global Antiviral Drugs Treatment Market: By Application
Global Antiviral Drugs Treatment Market: By Region
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651